Sprycel (dasatinib), a new oral drug for certain forms of leukemia

There's lots of excitement about Sprycel (dasatinib), a new oral drug for certain forms of leukemia.

It's for patients who are resistant to or can't take other treatments...including Gleevec (imatinib).

Sprycel is a tyrosine kinase inhibitor...similar to Gleevec.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote